<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02019407</url>
  </required_header>
  <id_info>
    <org_study_id>4-2013-0639</org_study_id>
    <nct_id>NCT02019407</nct_id>
  </id_info>
  <brief_title>Prospective Randomized Study on Clinical Effectiveness of Carvo-Tricuspid Isthmus Block in Patients With Paroxysmal Atrial Fibrillation</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective Randomized Study on Clinical Effectiveness of Carvo-Tricuspid Isthmus (CTI) Block
      in Patients with Paroxysmal Atrial Fibrillation (PAF) will be performed. Study will be
      composed with two arms including 4 pulmonary vein isolation and pulmonary vein isolation with
      CTI block. After that all patients will be followed up by HRS(Heart Rhythm Society) 2010
      expert consensus guideline.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">April 26, 2018</completion_date>
  <primary_completion_date type="Actual">April 26, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Recurrence of Atrial fibrillation (AF free survival)</measure>
    <time_frame>3 month after catheter ablation</time_frame>
    <description>clinical recurrence of AF after catheter ablation</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">128</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>CTI group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CTI(Cavo-Tricuspid Isthmus)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non CTI group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Non CTI (Cavo-Tricuspid Isthmus)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PVI, CTI block</intervention_name>
    <description>PVI (pulmonary isolation)
Catheter ablation of cavo-tricuspid isthmus line for treatment of atrial fibrillation
Catheter is inserted into inferior venacava (IVC) and right atrium (RA) via femoral vein. And the procedure is to block bidirectionally between inferior venacava (IVC) and the annulus of tricuspid valve (TV) by using electrical energy of catheter tip.</description>
    <arm_group_label>CTI group</arm_group_label>
    <other_name>radiofrequency catheter ablation (RFCA), Catheter ablation of cavo-tricuspid isthmus line for treatment of atrial flutter</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PVI</intervention_name>
    <description>PVI (pulmonary isolation)</description>
    <arm_group_label>Non CTI group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with documented AF

          -  Drug refractory AF

          -  Non-valvular AF

          -  No structural cardiac disease

          -  No intracardiac thrombi in cardiac CT and TEE

        Exclusion Criteria:

          -  permanent AF refractory to electrical cardioversion

          -  LA size &gt;55 mm as measured by echocardiography

          -  AF with valvular disease

          -  associated structural heart disease other than left ventricular hypertrophy

          -  prior AF ablation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>ivision of Cardiology, Yonsei University Health System, Yonsei University College of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <reference>
    <citation>Mohanty S, Mohanty P, Di Biase L, Bai R, Santangeli P, Casella M, Dello Russo A, Tondo C, Themistoclakis S, Raviele A, Rossillo A, Corrado A, Pelargonio G, Forleo G, Natale A. Results from a single-blind, randomized study comparing the impact of different ablation approaches on long-term procedure outcome in coexistent atrial fibrillation and flutter (APPROVAL). Circulation. 2013 May 7;127(18):1853-60. doi: 10.1161/CIRCULATIONAHA.113.001855. Epub 2013 Apr 9.</citation>
    <PMID>23572499</PMID>
  </reference>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>December 6, 2013</study_first_submitted>
  <study_first_submitted_qc>December 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 24, 2013</study_first_posted>
  <last_update_submitted>March 26, 2019</last_update_submitted>
  <last_update_submitted_qc>March 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>atrial fibrillation</keyword>
  <keyword>atrial flutter</keyword>
  <keyword>catheter ablation</keyword>
  <keyword>cavo-tricuspid isthmus block</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

